---
document_datetime: 2025-12-02 06:16:05
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/clopidogrel-bms.html
document_name: clopidogrel-bms.html
version: success
processing_time: 0.1010469
conversion_datetime: 2025-12-25 01:11:01.091878
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Clopidogrel BMS

[RSS](/en/individual-human-medicine.xml/66470)

##### Withdrawn

This medicine's authorisation has been withdrawn

clopidogrel Medicine Human Withdrawn

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)
- [More information on Clopidogrel BMS](#related-medicines)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 16 July 2008 the European Commission issued a marketing authorisation valid throughout the European Union for the medicinal product Clopidogrel BMS, clopidogrel, which had been approved for the prevention of atherothrombotic events in:

- Patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.
- Patients suffering from acute coronary syndrome: Non-ST segment elevation acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (ASA). ST segment elevation acute myocardial infarction, in combination with ASA in medically treated patients eligible for thrombolytic therapy.

The marketing authorisation holder (MAH) responsible for Clopidogrel BMS was Bristol Myers Squibb Pharma EEIG. The European Commission was notified by letter dated 20 October 2009 of the MAH's decision to voluntarily withdraw the marketing authorisation for Clopidogrel BMS for commercial reasons.

On 12 November 2009 the European Commission issued a decision to withdraw the marketing authorisation for Clopidogrel BMS. Pursuant to this decision the European Public Assessment Report for Clopidogrel BMS is updated to reflect that the marketing authorisation is no longer valid.

Clopidogrel BMS : EPAR - Summary for the public

English (EN) (268.18 KB - PDF)

**First published:** 11/11/2009

**Last updated:** 11/11/2009

[View](/en/documents/overview/clopidogrel-bms-epar-summary-public_en.pdf)

[Other languages (21)](#file-language-dropdown-692)

български (BG) (441.64 KB - PDF)

**First published:**

11/11/2009

**Last updated:**

11/11/2009

[View](/bg/documents/overview/clopidogrel-bms-epar-summary-public_bg.pdf)

español (ES) (270.83 KB - PDF)

**First published:**

11/11/2009

**Last updated:**

11/11/2009

[View](/es/documents/overview/clopidogrel-bms-epar-summary-public_es.pdf)

čeština (CS) (415.4 KB - PDF)

**First published:**

11/11/2009

**Last updated:**

11/11/2009

[View](/cs/documents/overview/clopidogrel-bms-epar-summary-public_cs.pdf)

dansk (DA) (271.04 KB - PDF)

**First published:**

11/11/2009

**Last updated:**

11/11/2009

[View](/da/documents/overview/clopidogrel-bms-epar-summary-public_da.pdf)

Deutsch (DE) (272.03 KB - PDF)

**First published:**

11/11/2009

**Last updated:**

11/11/2009

[View](/de/documents/overview/clopidogrel-bms-epar-summary-public_de.pdf)

eesti keel (ET) (269.11 KB - PDF)

**First published:**

11/11/2009

**Last updated:**

11/11/2009

[View](/et/documents/overview/clopidogrel-bms-epar-summary-public_et.pdf)

ελληνικά (EL) (478.25 KB - PDF)

**First published:**

11/11/2009

**Last updated:**

11/11/2009

[View](/el/documents/overview/clopidogrel-bms-epar-summary-public_el.pdf)

français (FR) (271.98 KB - PDF)

**First published:**

11/11/2009

**Last updated:**

11/11/2009

[View](/fr/documents/overview/clopidogrel-bms-epar-summary-public_fr.pdf)

italiano (IT) (270.07 KB - PDF)

**First published:**

11/11/2009

**Last updated:**

11/11/2009

[View](/it/documents/overview/clopidogrel-bms-epar-summary-public_it.pdf)

latviešu valoda (LV) (413.55 KB - PDF)

**First published:**

11/11/2009

**Last updated:**

11/11/2009

[View](/lv/documents/overview/clopidogrel-bms-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (633.98 KB - PDF)

**First published:**

11/11/2009

**Last updated:**

11/11/2009

[View](/lt/documents/overview/clopidogrel-bms-epar-summary-public_lt.pdf)

magyar (HU) (402.65 KB - PDF)

**First published:**

11/11/2009

**Last updated:**

11/11/2009

[View](/hu/documents/overview/clopidogrel-bms-epar-summary-public_hu.pdf)

Malti (MT) (413.05 KB - PDF)

**First published:**

11/11/2009

**Last updated:**

11/11/2009

[View](/mt/documents/overview/clopidogrel-bms-epar-summary-public_mt.pdf)

Nederlands (NL) (270.69 KB - PDF)

**First published:**

11/11/2009

**Last updated:**

11/11/2009

[View](/nl/documents/overview/clopidogrel-bms-epar-summary-public_nl.pdf)

polski (PL) (419.76 KB - PDF)

**First published:**

11/11/2009

**Last updated:**

11/11/2009

[View](/pl/documents/overview/clopidogrel-bms-epar-summary-public_pl.pdf)

português (PT) (271.17 KB - PDF)

**First published:**

11/11/2009

**Last updated:**

11/11/2009

[View](/pt/documents/overview/clopidogrel-bms-epar-summary-public_pt.pdf)

română (RO) (380.18 KB - PDF)

**First published:**

11/11/2009

**Last updated:**

11/11/2009

[View](/ro/documents/overview/clopidogrel-bms-epar-summary-public_ro.pdf)

slovenčina (SK) (430.76 KB - PDF)

**First published:**

11/11/2009

**Last updated:**

11/11/2009

[View](/sk/documents/overview/clopidogrel-bms-epar-summary-public_sk.pdf)

slovenščina (SL) (366.07 KB - PDF)

**First published:**

11/11/2009

**Last updated:**

11/11/2009

[View](/sl/documents/overview/clopidogrel-bms-epar-summary-public_sl.pdf)

Suomi (FI) (271.02 KB - PDF)

**First published:**

11/11/2009

**Last updated:**

11/11/2009

[View](/fi/documents/overview/clopidogrel-bms-epar-summary-public_fi.pdf)

svenska (SV) (269.45 KB - PDF)

**First published:**

11/11/2009

**Last updated:**

11/11/2009

[View](/sv/documents/overview/clopidogrel-bms-epar-summary-public_sv.pdf)

## Product information

Clopidogrel BMS : EPAR - Product Information

English (EN) (696.54 KB - PDF)

**First published:** 11/11/2009

**Last updated:** 11/11/2009

[View](/en/documents/product-information/clopidogrel-bms-epar-product-information_en.pdf)

[Other languages (21)](#file-language-dropdown-275)

български (BG) (851.28 KB - PDF)

**First published:**

11/11/2009

**Last updated:**

11/11/2009

[View](/bg/documents/product-information/clopidogrel-bms-epar-product-information_bg.pdf)

español (ES) (719.8 KB - PDF)

**First published:**

11/11/2009

**Last updated:**

11/11/2009

[View](/es/documents/product-information/clopidogrel-bms-epar-product-information_es.pdf)

čeština (CS) (844.3 KB - PDF)

**First published:**

11/11/2009

**Last updated:**

11/11/2009

[View](/cs/documents/product-information/clopidogrel-bms-epar-product-information_cs.pdf)

dansk (DA) (695.96 KB - PDF)

**First published:**

11/11/2009

**Last updated:**

11/11/2009

[View](/da/documents/product-information/clopidogrel-bms-epar-product-information_da.pdf)

Deutsch (DE) (738.88 KB - PDF)

**First published:**

11/11/2009

**Last updated:**

11/11/2009

[View](/de/documents/product-information/clopidogrel-bms-epar-product-information_de.pdf)

eesti keel (ET) (668.61 KB - PDF)

**First published:**

11/11/2009

**Last updated:**

11/11/2009

[View](/et/documents/product-information/clopidogrel-bms-epar-product-information_et.pdf)

ελληνικά (EL) (1.03 MB - PDF)

**First published:**

11/11/2009

**Last updated:**

11/11/2009

[View](/el/documents/product-information/clopidogrel-bms-epar-product-information_el.pdf)

français (FR) (736.31 KB - PDF)

**First published:**

11/11/2009

**Last updated:**

11/11/2009

[View](/fr/documents/product-information/clopidogrel-bms-epar-product-information_fr.pdf)

italiano (IT) (714.25 KB - PDF)

**First published:**

11/11/2009

**Last updated:**

11/11/2009

[View](/it/documents/product-information/clopidogrel-bms-epar-product-information_it.pdf)

latviešu valoda (LV) (915.72 KB - PDF)

**First published:**

11/11/2009

**Last updated:**

11/11/2009

[View](/lv/documents/product-information/clopidogrel-bms-epar-product-information_lv.pdf)

lietuvių kalba (LT) (1.24 MB - PDF)

**First published:**

11/11/2009

**Last updated:**

11/11/2009

[View](/lt/documents/product-information/clopidogrel-bms-epar-product-information_lt.pdf)

magyar (HU) (782.77 KB - PDF)

**First published:**

11/11/2009

**Last updated:**

11/11/2009

[View](/hu/documents/product-information/clopidogrel-bms-epar-product-information_hu.pdf)

Malti (MT) (827.24 KB - PDF)

**First published:**

11/11/2009

**Last updated:**

11/11/2009

[View](/mt/documents/product-information/clopidogrel-bms-epar-product-information_mt.pdf)

Nederlands (NL) (693.25 KB - PDF)

**First published:**

11/11/2009

**Last updated:**

11/11/2009

[View](/nl/documents/product-information/clopidogrel-bms-epar-product-information_nl.pdf)

polski (PL) (936.49 KB - PDF)

**First published:**

11/11/2009

**Last updated:**

11/11/2009

[View](/pl/documents/product-information/clopidogrel-bms-epar-product-information_pl.pdf)

português (PT) (691.04 KB - PDF)

**First published:**

11/11/2009

**Last updated:**

11/11/2009

[View](/pt/documents/product-information/clopidogrel-bms-epar-product-information_pt.pdf)

română (RO) (824.44 KB - PDF)

**First published:**

11/11/2009

**Last updated:**

11/11/2009

[View](/ro/documents/product-information/clopidogrel-bms-epar-product-information_ro.pdf)

slovenčina (SK) (825.02 KB - PDF)

**First published:**

11/11/2009

**Last updated:**

11/11/2009

[View](/sk/documents/product-information/clopidogrel-bms-epar-product-information_sk.pdf)

slovenščina (SL) (765.81 KB - PDF)

**First published:**

11/11/2009

**Last updated:**

11/11/2009

[View](/sl/documents/product-information/clopidogrel-bms-epar-product-information_sl.pdf)

Suomi (FI) (677.55 KB - PDF)

**First published:**

11/11/2009

**Last updated:**

11/11/2009

[View](/fi/documents/product-information/clopidogrel-bms-epar-product-information_fi.pdf)

svenska (SV) (664.87 KB - PDF)

**First published:**

11/11/2009

**Last updated:**

11/11/2009

[View](/sv/documents/product-information/clopidogrel-bms-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** N/0012 26/10/2009

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Clopidogrel BMS : EPAR - All Authorised presentations

English (EN) (227.86 KB - PDF)

**First published:** 05/11/2008

**Last updated:** 05/11/2008

[View](/en/documents/all-authorised-presentations/clopidogrel-bms-epar-all-authorised-presentations_en.pdf)

[Other languages (21)](#file-language-dropdown-19)

български (BG) (350.69 KB - PDF)

**First published:**

05/11/2008

**Last updated:**

05/11/2008

[View](/bg/documents/all-authorised-presentations/clopidogrel-bms-epar-all-authorised-presentations_bg.pdf)

español (ES) (229.27 KB - PDF)

**First published:**

05/11/2008

**Last updated:**

05/11/2008

[View](/es/documents/all-authorised-presentations/clopidogrel-bms-epar-all-authorised-presentations_es.pdf)

čeština (CS) (317.55 KB - PDF)

**First published:**

05/11/2008

**Last updated:**

05/11/2008

[View](/cs/documents/all-authorised-presentations/clopidogrel-bms-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (251.25 KB - PDF)

**First published:**

05/11/2008

**Last updated:**

05/11/2008

[View](/da/documents/all-authorised-presentations/clopidogrel-bms-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (227.85 KB - PDF)

**First published:**

05/11/2008

**Last updated:**

05/11/2008

[View](/de/documents/all-authorised-presentations/clopidogrel-bms-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (228.82 KB - PDF)

**First published:**

05/11/2008

**Last updated:**

05/11/2008

[View](/et/documents/all-authorised-presentations/clopidogrel-bms-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (324.29 KB - PDF)

**First published:**

05/11/2008

**Last updated:**

05/11/2008

[View](/el/documents/all-authorised-presentations/clopidogrel-bms-epar-all-authorised-presentations_el.pdf)

français (FR) (229.2 KB - PDF)

**First published:**

05/11/2008

**Last updated:**

05/11/2008

[View](/fr/documents/all-authorised-presentations/clopidogrel-bms-epar-all-authorised-presentations_fr.pdf)

italiano (IT) (228.11 KB - PDF)

**First published:**

05/11/2008

**Last updated:**

05/11/2008

[View](/it/documents/all-authorised-presentations/clopidogrel-bms-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (321.11 KB - PDF)

**First published:**

05/11/2008

**Last updated:**

05/11/2008

[View](/lv/documents/all-authorised-presentations/clopidogrel-bms-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (532.46 KB - PDF)

**First published:**

05/11/2008

**Last updated:**

05/11/2008

[View](/lt/documents/all-authorised-presentations/clopidogrel-bms-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (318.5 KB - PDF)

**First published:**

05/11/2008

**Last updated:**

05/11/2008

[View](/hu/documents/all-authorised-presentations/clopidogrel-bms-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (316.67 KB - PDF)

**First published:**

05/11/2008

**Last updated:**

05/11/2008

[View](/mt/documents/all-authorised-presentations/clopidogrel-bms-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (227.21 KB - PDF)

**First published:**

05/11/2008

**Last updated:**

05/11/2008

[View](/nl/documents/all-authorised-presentations/clopidogrel-bms-epar-all-authorised-presentations_nl.pdf)

polski (PL) (281.38 KB - PDF)

**First published:**

05/11/2008

**Last updated:**

05/11/2008

[View](/pl/documents/all-authorised-presentations/clopidogrel-bms-epar-all-authorised-presentations_pl.pdf)

português (PT) (251.2 KB - PDF)

**First published:**

05/11/2008

**Last updated:**

05/11/2008

[View](/pt/documents/all-authorised-presentations/clopidogrel-bms-epar-all-authorised-presentations_pt.pdf)

română (RO) (313.4 KB - PDF)

**First published:**

05/11/2008

**Last updated:**

05/11/2008

[View](/ro/documents/all-authorised-presentations/clopidogrel-bms-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (281.55 KB - PDF)

**First published:**

05/11/2008

**Last updated:**

05/11/2008

[View](/sk/documents/all-authorised-presentations/clopidogrel-bms-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (271.82 KB - PDF)

**First published:**

05/11/2008

**Last updated:**

05/11/2008

[View](/sl/documents/all-authorised-presentations/clopidogrel-bms-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (228.72 KB - PDF)

**First published:**

05/11/2008

**Last updated:**

05/11/2008

[View](/fi/documents/all-authorised-presentations/clopidogrel-bms-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (250.54 KB - PDF)

**First published:**

05/11/2008

**Last updated:**

05/11/2008

[View](/sv/documents/all-authorised-presentations/clopidogrel-bms-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Clopidogrel BMS Active substance clopidogrel (as hydrogen sulfate) International non-proprietary name (INN) or common name clopidogrel Therapeutic area (MeSH)

- Stroke
- Peripheral Vascular Diseases
- Myocardial Infarction
- Acute Coronary Syndrome

Anatomical therapeutic chemical (ATC) code B01AC04

### Pharmacotherapeutic group

Antithrombotic agents

### Therapeutic indication

Clopidogrel is indicated in adults for the prevention of atherothrombotic events in:

- Patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.

- Patients suffering from acute coronary syndrome:

Non-ST segment elevation acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (ASA).

ST segment elevation acute myocardial infarction, in combination with ASA in medically treated patients eligible for thrombolytic therapy.

## Authorisation details

EMA product number EMEA/H/C/000974 Marketing authorisation holder

Bristol-Myers Squibb Pharma EEIG

Plaza 254

Marketing authorisation issued 16/07/2008 Withdrawal of marketing authorisation 12/11/2009 Revision 3

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Clopidogrel BMS : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (250.77 KB - PDF)

**First published:** 11/11/2009

**Last updated:** 11/11/2009

[View](/en/documents/procedural-steps-after/clopidogrel-bms-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

## Initial marketing authorisation documents

Committee for medicinal products for human use summary of positive opinion for Clopidogrel BMS

Reference Number: EMEA/CHMP/191695/2008-corr

English (EN) (34.96 KB - PDF)

**First published:** 06/05/2008

**Last updated:** 06/05/2008

[View](/en/documents/smop-initial/committee-medicinal-products-human-use-summary-positive-opinion-clopidogrel-bms_en.pdf)

#### More information on Clopidogrel BMS

- [Clopidogrel - paediatric investigation plan](/en/medicines/human/paediatric-investigation-plans/clopidogrel-1)

**This page was last updated on** 26/01/2010

## Share this page

[Back to top](#main-content)